Dr. Georgina Long
Claim this profileMelanoma Institute Australia
Studies Skin Cancer
Studies Melanoma
15 reported clinical trials
17 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
Stage II
2Melanoma
Stage IV
metastatic
locally advanced
Clinical Trials Georgina Long is currently running
mRNA Vaccine + Immunotherapy
for Melanoma
This trial is testing if a combination of a personalized cancer vaccine (mRNA-4157) and an immune-boosting medication (pembrolizumab) can better prevent melanoma from returning in patients who have had their tumors surgically removed. Pembrolizumab has been shown to help prevent the return and spread of melanoma in patients who have had their tumors surgically removed.
Recruiting1 award Phase 26 criteria
Nivolumab Safety
for Cancer
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
Recruiting1 award Phase 2
More about Georgina Long
Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Georgina Long has experience with
- Nivolumab
- Pembrolizumab
- Relatlimab
- Ipilimumab
- BMS-986016
- Placebo
Breakdown of trials Georgina Long has run
Skin Cancer
Melanoma
Cancer
Malignant Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Georgina Long specialize in?
Georgina Long focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Georgina Long currently recruiting for clinical trials?
Yes, Georgina Long is currently recruiting for 2 clinical trials in North Sydney New South Wales. If you're interested in participating, you should apply.
Are there any treatments that Georgina Long has studied deeply?
Yes, Georgina Long has studied treatments such as Nivolumab, Pembrolizumab, Relatlimab.
What is the best way to schedule an appointment with Georgina Long?
Apply for one of the trials that Georgina Long is conducting.
What is the office address of Georgina Long?
The office of Georgina Long is located at: Melanoma Institute Australia, North Sydney, New South Wales 2060 Australia. This is the address for their practice at the Melanoma Institute Australia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.